Abstract
The introduction of combination antiretroviral therapy has been associated with a dramatic clinical improvement in children with human immunodeficiency virus infection. However, the uptake of antiretroviral therapy has been variable across Europe. The Paediatric European Network for the Treatment of AIDS Steering Committee has performed a systematic literature review of paediatric antiretroviral therapy trials. An analysis of the evidence base for the commencement and maintenance of antiretroviral therapy was produced. Suggestions for when to commence antiretroviral therapy, which drugs to start with and how to monitor and sequence drug regimens are given.
Conclusion The aim of these guidelines is to help in obtaining equity of access to a uniformly high standard of care for children with human immunodeficiency virus infection in all European countries.
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Additional information
Received: 15 November 1999 / Accepted: 16 February 2000
Rights and permissions
About this article
Cite this article
Sharland, M., Gibb, D., Giaquinto, C. et al. Current evidence for the use of paediatric antiretroviral therapy – a PENTA analysis. Eur J Pediatr 159, 649–656 (2000). https://doi.org/10.1007/PL00008400
Issue Date:
DOI: https://doi.org/10.1007/PL00008400